期刊文献+

^(18)F-Fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma 被引量:3

^(18)F-Fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma
下载PDF
导出
摘要 AIM To compare ^(18)F-fluorodeoxyglucose positron emission tomography/computed tomography(^(18)F-FDG PET/CT) features in gastric lymphoma and gastric carcinoma.METHODS Patients with newly diagnosed gastric lymphoma or gastric carcinoma who underwent ^(18)F-FDG PET/CT prior to treatment were included in this study. We reviewed and analyzed the PET/CT features of gastric wall lesions,including FDG avidity,pattern(focal/diffuse),and intensity [maximal standard uptake value:(SUVmax)]. The correlation of SUVmax with gastricclinicopathological variables was investigated by χ~2 test,and receiver-operating characteristic(ROC) curve analysis was performed to determine the differential diagnostic value of SUVmax-associated parameters in gastric lymphoma and gastric carcinoma. RESULTS Fifty-two patients with gastric lymphoma and 73 with gastric carcinoma were included in this study. Abnormal gastric FDG accumulation was found in 49 patients(94.23%) with gastric lymphoma and 65 patients(89.04%) with gastric carcinoma. Gastric lymphoma patients predominantly presented with type Ⅰ and type Ⅱ lesions,whereas gastric carcinoma patients mainly had type Ⅲ lesions. The SUVmax(13.39 ± 9.24 vs 8.35 ± 5.80,P < 0.001) and SUVmax/THKmax(maximal thickness)(7.96 ± 4.02 vs 4.88 ± 3.32,P < 0.001) were both higher in patients with gastric lymphoma compared with gastric carcinoma. ROC curve analysis suggested a better performance of SUVmax/THKmax in the evaluation of gastric lesions between gastric lymphoma and gastric carcinoma in comparison with that of SUVmax alone.CONCLUSION PET/CT features differ between gastric lymphoma and carcinoma,which can improve PET/CT evaluation of gastric wall lesions and help differentiate gastric lymphoma from gastric carcinoma. AIM To compare 18F-fluorodeoxyglucose positron emission tomography/computed tomography(18F-FDG PET/CT) features in gastric lymphoma and gastric carcinoma.METHODS Patients with newly diagnosed gastric lymphoma or gastric carcinoma who underwent 18F-FDG PET/CT prior to treatment were included in this study. We reviewed and analyzed the PET/CT features of gastric wall lesions,including FDG avidity,pattern(focal/diffuse),and intensity [maximal standard uptake value:(SUVmax)]. The correlation of SUVmax with gastricclinicopathological variables was investigated by χ2 test,and receiver-operating characteristic(ROC) curve analysis was performed to determine the differential diagnostic value of SUVmax-associated parameters in gastric lymphoma and gastric carcinoma. RESULTS Fifty-two patients with gastric lymphoma and 73 with gastric carcinoma were included in this study. Abnormal gastric FDG accumulation was found in 49 patients(94.23%) with gastric lymphoma and 65 patients(89.04%) with gastric carcinoma. Gastric lymphoma patients predominantly presented with type Ⅰ and type Ⅱ lesions,whereas gastric carcinoma patients mainly had type Ⅲ lesions. The SUVmax(13.39 ± 9.24 vs 8.35 ± 5.80,P < 0.001) and SUVmax/THKmax(maximal thickness)(7.96 ± 4.02 vs 4.88 ± 3.32,P < 0.001) were both higher in patients with gastric lymphoma compared with gastric carcinoma. ROC curve analysis suggested a better performance of SUVmax/THKmax in the evaluation of gastric lesions between gastric lymphoma and gastric carcinoma in comparison with that of SUVmax alone.CONCLUSION PET/CT features differ between gastric lymphoma and carcinoma,which can improve PET/CT evaluation of gastric wall lesions and help differentiate gastric lymphoma from gastric carcinoma.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第34期7787-7796,共10页 世界胃肠病学杂志(英文版)
基金 Supported by the National Natural Science Foundation of China,No.81501984 and No.81601377 Tianjin Municipal Bureau of Health Science and Technology,No.2015KZ084 and No.2013KZ088 Tianjin Medical University Science,No.2013KYQ07
关键词 GASTRIC LYMPHOMAS GASTRIC CARCINOMAS 18F-FLUORODEOXYGLUCOSE positron emission tomography/ computed TOMOGRAPHY MAXIMAL standard uptake value MAXIMAL thickness Differential diagnosis Gastric lymphomas Gastric carcinomas 18F-fluorodeoxyglucose positron emission tomography/ computed tomography Maximal standard uptake value Maximal thickness Differential diagnosis
  • 相关文献

参考文献35

  • 1Andriani A,Zullo A,Di Raimondo F,Patti C,Tedeschi L,Recine U,Caruso L,Bonanno G,Chiarenza A,Lizzani G,Miedico A,Romanelli A,Costa A,Linea C,Marrone C,Mirto S,Mistretta A,Montalbano L,Restivo G,Vinci M,Bibas M,Hassan C,Stella F,Cottone M,Morini S.Clinical and endoscopic presentation of primary gastric lymphoma:a multicentre study. Alimentary Pharmacology and Therapeutics . 2006
  • 2M Hoffmann,S W?hrer,A Becherer,A Chott,B Streubel,K Kletter,M Raderer.18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Annals of Oncology . 2006
  • 3Im HJ,Pak K,Cheon GJ, et al.Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer:a meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging . 2015
  • 4Yasumitsu Hirose,Hayato Kaida,Masatoshi Ishibashi,Jun Uozumi,Shunji Arikawa,Seiji Kurata,Naofumi Hayabuchi,Keita Nakahara,Koichi Ohshima.??Comparison Between Endoscopic Macroscopic Classification and F-18 FDG PET Findings in Gastric Mucosa–Associated Lymphoid Tissue Lymphoma Patients(J)Clinical Nuclear Medicine . 2012 (2)
  • 5Ahmet Turan Ilica,Kenan Kocacelebi,Recep Savas,Asli Ayan.??Imaging of Extranodal Lymphoma With PET/CT(J)Clinical Nuclear Medicine . 2011 (10)
  • 6Jun HoYi,Seok JinKim,Joon YoungChoi,Young HyehKo,Byung‐TaeKim,Won SeogKim.??<sup>18</sup>F‐FDG uptake and its clinical relevance in primary gastric lymphoma(J)Hematol. Oncol. . 2010 (2)
  • 7Vasavi Paidpally,Alin Chirindel,Stella Lam,Nishant Agrawal,Harry Quon,Rathan M Subramaniam.??FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma(J)Imaging Med. . 2012 (6)
  • 8Punit Sharma,Sudhir KC Suman,Harmandeep Singh,Atul Sharma,Chandrasekhar Bal,Arun Malhotra,Rakesh Kumar.Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment[J].Leukemia & Lymphoma.2013(5)
  • 9Pak, Kyoungjune,Cheon, Gi Jeong,Nam, Hyun-Yeol,Kim, Seong-Jang,Kang, Keon Wook,Chung, June-Key,Kim, E Edmund,Lee, Dong Soo.??Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis(J)The Journal of Nuclear Medicine . 2014 (6)
  • 10Jiang Wu,Hong Zhu,Kai Li,Xin?Gang Wang,Yi Gui,Guang?Ming Lu.??18F?fluorodeoxyglucose positron emission tomography/computed tomographyfindings of gastric lymphoma: Comparisons with gastric cancer(J)Oncology Letters . 2014 (4)

二级参考文献99

  • 1Thomas CR Jr, Share R. Gastrointestinal lymphoma. Med Pediatr Oncol 1991; 19:48-60.
  • 2Tedeschi L, Romanelli A, Dallavalle G, Tavani E, Arnoldi E, Vinci M, Mortara G, Bedoni P, Labianca R, Luporini G. Stages I and II non-Hodgkin's lymphoma of the gastrointestinal tract. Retrospective analysis of 79 patients and review of the literature. J Clin Gastroenterol 1994; 18:99-104.
  • 3Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575-577.
  • 4Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A,Savio E, Capella C, Pedrinis E, Saletti P, Morandi E, Santandrea G, Cavalli F. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997; 26:527-537.
  • 5Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, Pedrinis E, Novero D, Rinaldi P, Cazzaniga G, Biondi A,Wotherspoon A, Hancock BW, Smith P, Souhami R, Cotter FE,Cavalli F, Zucca E. International extranodal lymphoma study group: United Kingdom lymphoma group. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphoma: early analvsis of the LY03 cooperative trial. Blood 2002: 99:2541-2544.
  • 6Fiscilbach W. Primary gastric lymphoma of MALT: considerations of pathogenesis, diagnosis and therapy. Can J Gastroenterol 2000; 14(Suppl D): 44D-50D.
  • 7Kocher M, Muller RP, Ross D, Hoederath A, Sack H. Radiotherapy for treatment of localized non-Hodgkin's lymphoma.Radiother Oncol 1997; 42:37-41.
  • 8Park SH, Han JK, Kim TK, Lee JW, Kim SH, Kim YI, Choi BI,Yeon KM, Han MC. Unusual gastric tumors: radiologic-pathologic correlation. Radiographics 1999; 19:1435-1446.
  • 9Brown JA, Carson BW,Gascoyne RD, Cooperberg PL, Connors JM, Mason AC. Low grade gastric MALT lymphoma: radioraphic findings. Clin Radiol 2000; 55:384-389.
  • 10Chou CK, Chen LT, Sheu RS, Yang CW, Wang ML, Jaw TS, Liu GC. MRI manifestations of gastrointestinal lymphoma. Abdom Imaging 1994; 19:495-500.

共引文献23

同被引文献28

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部